Other relevant information

ORYZON GENOMICS, S.A.

• • 26/10/2020
  • 07:12
  • ORYZON GENOMICS, S.A.
  • Interim management report
  • La sociedad remite declaración intermedia de gestión del tercer trimestre de 2020
  • Register number: 5197
• • 22/09/2020
  • 17:59
  • ORYZON GENOMICS, S.A.
  • Announcement of general shareholders’ meeting
  • Oryzon Genomics, S.A. informa sobre los acuerdos adoptados por la Junta General Ordinaria de Accionistas
  • Register number: 4567
• • 17/09/2020
  • 09:00
  • ORYZON GENOMICS, S.A.
  • Other relevant information
  • ORYZON presents efficacy and safety results of its CLEPSIDRA trial with iadademstat in small cell lung cancer patients at ESMO-2020
  • Register number: 4477
• • 22/08/2020
  • 07:11
  • ORYZON GENOMICS, S.A.
  • Announcement of general shareholders’ meeting
  • Complementary notice call of the Ordinary Shareholders Meeting
  • Register number: 4105
• • 31/07/2020
  • 07:17
  • ORYZON GENOMICS, S.A.
  • Announcement of general shareholders’ meeting
  • Call of the Ordinary General Shareholders’ Meeting of Oryzon Genomics, S.A.
  • Register number: 3839
• • 22/07/2020
  • 18:11
  • ORYZON GENOMICS, S.A.
  • Half-yearly financial reports and audit reports/limited audit review
  • La sociedad remite información financiera del primer semestre de 2020
  • Register number: 3545
• • 29/06/2020
  • 13:49
  • ORYZON GENOMICS, S.A.
  • Total number of voting rights and capital 
  • Actualización del capital social, número de acciones y número de derechos de votos tras procederse el 29 de junio de 2020 a la inscripción ante el Registro Mercantil de Madrid de escritura de aumento de capital
  • Register number: 3043
• • 26/06/2020
  • 21:32
  • ORYZON GENOMICS, S.A.
  • On financial instruments
  • Otorgamiento de la escritura de aumento de capital
  • Register number: 3030
• • 12/06/2020
  • 08:34
  • ORYZON GENOMICS, S.A.
  • Other relevant information
  • ORYZON presents positive efficacy data of iadademstat from its ongoing Phase IIa clinical trial in acute myeloid leukemia at EHA-2020
  • Register number: 2731
• • 11/05/2020
  • 19:11
  • ORYZON GENOMICS, S.A.
  • On corporate governance
  • ORYZON submits a press release regarding the composition of its Board of Directors
  • Register number: 2161